- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00002356
The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes
An Open-Label Study of the Safety and Efficacy of Intravitreal ISIS 2922 in Acquired Immune Deficiency Syndrome (AIDS) Patients With Cytomegalovirus Retinitis (NOTE: Restricted to Patients Who Rollover From Another Controlled ISIS 2922 Trial)
To evaluate the efficacy and safety of ISIS 2922 in AIDS patients with Cytomegalovirus ( CMV ) retinitis who are unresponsive or intolerant to ganciclovir and/or foscarnet but are otherwise ineligible for ISIS Pharmaceuticals' controlled trials OR who have failed ISIS 2922 therapy on another controlled clinical trial.
PER 2/8/96 AMENDMENT: Patients must rollover from another ISIS 2922 controlled trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
California
-
Irvine, California, United States, 92715
- UCI College of Medicine
-
Los Angeles, California, United States, 90017
- Retina - Vitreous Associates Med Group
-
Pasadena, California, United States, 911052536
- Community Eye Med Group
-
San Diego, California, United States, 92134
- San Diego Naval Hosp
-
San Francisco, California, United States, 94110
- Univ of California San Francisco / SF Gen Hosp
-
San Jose, California, United States, 95128
- Santa Clara Valley Med Ctr
-
-
Colorado
-
Denver, Colorado, United States, 80262
- Univ of Colorado Health Sciences Ctr
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20036
- Dr Alan Palestine
-
-
Florida
-
Fort Lauderdale, Florida, United States, 33060
- Dr Julio Perez
-
Miami, Florida, United States, 33136
- Bascon Palmer Eye Institute
-
-
Georgia
-
Atlanta, Georgia, United States, 30327
- Georgia Retina
-
Atlanta, Georgia, United States, 30322
- Emory Univ School of Medicine / Emory Eye Ctr
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Univ of Illinois
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana Univ Med Ctr
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112
- Tulane Univ
-
-
New York
-
New York, New York, United States, 10028
- Vitreo - Retinal Consultants
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Charlotte Eye Ear Nose & Throat Association
-
Durham, North Carolina, United States, 27710
- Duke Univ
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19102
- Hahnemann Univ Hosp
-
Philadelphia, Pennsylvania, United States, 191461192
- Graduate Hosp
-
-
Texas
-
Dallas, Texas, United States, 752359057
- Univ of Texas Southwestern Med Ctr of Dallas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
Houston, Texas, United States, 77004
- Vitreoretinal Consultants
-
-
Virginia
-
Norfolk, Virginia, United States, 23507
- Virginia Eye Consultants
-
-
Washington
-
Seattle, Washington, United States, 98104
- Novum Inc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
Patients must have:
- AIDS.
- CMV retinitis in one or both eyes that was previously treated but is presently uncontrolled.
- Intolerance or resistance to other therapies.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
- Eligibility to participate in a controlled clinical trial of ISIS 2922.
- External ocular infection in eye to be treated.
- Other herpetic infections of the retina, toxoplasma retinochoroiditis, or other diseases of the fundus in eye to be treated.
- Ocular condition that would obstruct visualization of the posterior ocular structures in eye to be treated.
- Retinal detachment in eye to be treated.
- Known or suspected allergy to phosphorothioate oligonucleotides.
- Silicone oil in eye to be treated.
- Syphilis.
- Clinical evidence of retinal pigment epithelial stippling.
- Pseudoretinitis pigmentosa.
Concurrent Medication:
Excluded:
- Foscarnet.
- Mellaril, Stelazine, Thorazine, and Clofazimine.
- Ethambutol / fluconazole combination.
- Other investigational drugs for CMV retinitis.
Patients with the following prior conditions are excluded:
- History of surgery to correct retinal detachment in eye to be treated.
- History of ganciclovir implant for treatment of CMV retinitis.
- History of intolerance to ISIS 2922.
- History of syphilis.
Required:
- Prior CMV retinitis therapy with ganciclovir, foscarnet, or ISIS 2922.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Masking: None (Open Label)
Collaborators and Investigators
Sponsor
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 251C
- ISIS 2922-CS7
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Fomivirsen sodium
-
Ionis Pharmaceuticals, Inc.CompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
Ionis Pharmaceuticals, Inc.CompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
Ionis Pharmaceuticals, Inc.CompletedHIV Infections | Cytomegalovirus RetinitisUnited States
-
Institut d'Anesthesiologie des Alpes MaritimesUniversité de Nice Sophia Antipolis; Medical University of GrenobleCompleted
-
University of DelawareCompletedBlood Pressure | Cerebrovascular ReactivityUnited States
-
Radboud University Medical CenterUnknownType1diabetes | Hypoglycemia UnawarenessNetherlands
-
Austin HealthCompletedSystemic Inflammatory Response Syndrome | Renal Impairment | OliguriaAustralia
-
Medical University of GrazCompleted
-
Brigham and Women's HospitalCompleted